Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes

Genetic testing for hereditary breast cancer is an integral part of individualized care in the new era of precision medicine. The accuracy of an assay is reliant on not only the technology and bioinformatics analysis utilized but also the experience and infrastructure required to correctly classify...

Full description

Saved in:
Bibliographic Details
Main Authors: T. Pesaran, R. Karam, R. Huether, S. Li, S. Farber-Katz, A. Chamberlin, H. Chong, H. LaDuca, A. Elliott
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:International Journal of Breast Cancer
Online Access:http://dx.doi.org/10.1155/2016/2469523
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566589091741696
author T. Pesaran
R. Karam
R. Huether
S. Li
S. Farber-Katz
A. Chamberlin
H. Chong
H. LaDuca
A. Elliott
author_facet T. Pesaran
R. Karam
R. Huether
S. Li
S. Farber-Katz
A. Chamberlin
H. Chong
H. LaDuca
A. Elliott
author_sort T. Pesaran
collection DOAJ
description Genetic testing for hereditary breast cancer is an integral part of individualized care in the new era of precision medicine. The accuracy of an assay is reliant on not only the technology and bioinformatics analysis utilized but also the experience and infrastructure required to correctly classify genetic variants as disease-causing. Interpreting the clinical significance of germline variants identified by hereditary cancer testing is complex and has a significant impact on the management of patients who are at increased cancer risk. In this review we give an overview of our clinical laboratory’s integrated approach to variant assessment. We discuss some of the nuances that should be considered in the assessment of genomic variants. In addition, we highlight lines of evidence such as functional assays and structural analysis that can be useful in the assessment of rare and complex variants.
format Article
id doaj-art-ff7a126d26014148b977a7317048e719
institution Kabale University
issn 2090-3170
2090-3189
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series International Journal of Breast Cancer
spelling doaj-art-ff7a126d26014148b977a7317048e7192025-02-03T01:03:46ZengWileyInternational Journal of Breast Cancer2090-31702090-31892016-01-01201610.1155/2016/24695232469523Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer GenesT. Pesaran0R. Karam1R. Huether2S. Li3S. Farber-Katz4A. Chamberlin5H. Chong6H. LaDuca7A. Elliott8Ambry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAAmbry Genetics Corp., 15 Argonaut, Aliso Viejo, CA 92656, USAGenetic testing for hereditary breast cancer is an integral part of individualized care in the new era of precision medicine. The accuracy of an assay is reliant on not only the technology and bioinformatics analysis utilized but also the experience and infrastructure required to correctly classify genetic variants as disease-causing. Interpreting the clinical significance of germline variants identified by hereditary cancer testing is complex and has a significant impact on the management of patients who are at increased cancer risk. In this review we give an overview of our clinical laboratory’s integrated approach to variant assessment. We discuss some of the nuances that should be considered in the assessment of genomic variants. In addition, we highlight lines of evidence such as functional assays and structural analysis that can be useful in the assessment of rare and complex variants.http://dx.doi.org/10.1155/2016/2469523
spellingShingle T. Pesaran
R. Karam
R. Huether
S. Li
S. Farber-Katz
A. Chamberlin
H. Chong
H. LaDuca
A. Elliott
Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
International Journal of Breast Cancer
title Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
title_full Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
title_fullStr Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
title_full_unstemmed Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
title_short Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
title_sort beyond dna an integrated and functional approach for classifying germline variants in breast cancer genes
url http://dx.doi.org/10.1155/2016/2469523
work_keys_str_mv AT tpesaran beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT rkaram beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT rhuether beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT sli beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT sfarberkatz beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT achamberlin beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT hchong beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT hladuca beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes
AT aelliott beyonddnaanintegratedandfunctionalapproachforclassifyinggermlinevariantsinbreastcancergenes